Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis

24 Aug 2016

Abstract excerpt

OBJECTIVE: To identify circulating microRNAs (miRNAs) linked to disease stage and disability in multiple sclerosis (MS). METHODS: Sera from 296 participants including patients with MS, other neurologic diseases (Alzheimer disease and amyotrophic lateral sclerosis), and inflammatory diseases (rheumatoid arthritis and asthma) and healthy controls (HCs) were tested. miRNA profiles were determined using LNA (locked...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to MicroRNA in disease regulation
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27606352
DOI: 10.1212/nxi.0000000000000267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosisPMID 27606352Read ↗

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosisSemantic proximity Read ↗

Identification of MS-specific serum miRNAs in an international multicenter studySemantic proximity Read ↗

Circulating microRNAs as biomarkers in progressive multiple sclerosisSemantic proximity Read ↗

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionSemantic proximity Read ↗

Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patientsSemantic proximity Read ↗

CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disordersSemantic proximity Read ↗

Regulated microRNAs in the CSF of patients with multiple sclerosisSemantic proximity Read ↗

Differential microRNA expression in blood in multiple sclerosisSemantic proximity Read ↗

miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.Semantic proximity Read ↗

miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisSemantic proximity Read ↗

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort studySemantic proximity Read ↗

Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.